- li>
- li>
- li>
- li>
- li>
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.25 | 0.43 | -42.24 |
| EPS, GAAP | 0.24 | 0.43 | 0.43 |
| Consensus Estimate | 0.30 | 0.30 | 0.64 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 1.48 | 0.64 | 131.94 |
| EPS, GAAP | 1.47 | 0.53 | 175.92 |
| Consensus Estimate | 1.55 | 0.62 | 151.62 |
| DAR | Industry Average | |
| P/E (TTM) | 11.13 | NA |
| P/E (Forward) | 11.24 | NA |
| PEG Ratio | 2.34 | 1.83 |
| Price/Sales | 0.96 | 1.57 |
| Beta | 1.40 | 0.63 |
| 5/11/2012 | Stocks to Watch: J.P. Morgan, McDermott, Arena Pharmaceuticals (WSJ.com) |
| 3/9/2012 | Why resort to guessing which company will perform best? (The Motley Fool) |
| 3/1/2012 | Just the facts, Fool. (The Motley Fool) |
| 2/25/2012 | S&P Ends the Week at a 12-Month High (Barrons.com) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)